Viking Global Investors Portfolio holdings
AUM $34.6B
1-Year Return
30.14%
This Quarter Return
+9.54%
1 Year Return
+30.14%
3 Year Return
+120.76%
5 Year Return
+143.03%
10 Year Return
+428.26%
AUM
$27.7B
AUM Growth
+$4.54B
(+20%)
Cap. Flow
+$2.76B
Cap. Flow
% of AUM
9.97%
Top 10 Holdings %
Top 10 Hldgs %
40.54%
Holding
104
New
32
Increased
27
Reduced
21
Closed
18
Top Buys
| 1 |
Microsoft
MSFT
|
+$956M |
| 2 |
TSMC
TSM
|
+$498M |
| 3 |
T-Mobile US
TMUS
|
+$488M |
| 4 |
Mercado Libre
MELI
|
+$437M |
| 5 |
AvalonBay Communities
AVB
|
+$381M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.07B |
| 2 |
Comcast
CMCSA
|
+$855M |
| 3 |
Uber
UBER
|
+$512M |
| 4 |
JD.com
JD
|
+$497M |
| 5 |
Salesforce
CRM
|
+$402M |
Sector Composition
| 1 | Healthcare | 30.8% |
| 2 | Technology | 24.93% |
| 3 | Financials | 16.07% |
| 4 | Consumer Discretionary | 12.86% |
| 5 | Industrials | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Darden Restaurants
DRI
$24.3B
| $145M | 0.52% |
1,436,057
-1,555,579
| -52% | -$157M |
|
52
Elevance Health
ELV
$69.5B
| $140M | 0.51% |
+522,405
| New | +$140M |
|
53
VeriSign
VRSN
$26.9B
| $134M | 0.48% |
+653,102
| New | +$134M |
|
|
BPMC
54
DELISTED
Blueprint Medicines
BPMC
| $133M | 0.48% |
1,430,767
-198,949
| -12% | -$18.4M |
|
55
Everest Group
EG
$14B
| $130M | 0.47% |
660,231
+242,008
| +58% | +$47.8M |
|
56
Sea Limited
SE
$111B
| $126M | 0.46% |
819,546
-907,834
| -53% | -$140M |
|
57
Unity
U
$19.3B
| $123M | 0.44% |
+1,409,981
| New | +$123M |
|
58
Cooper Companies
COO
$12.8B
| $119M | 0.43% |
1,407,308
+25,216
| +2% | +$2.13M |
|
59
Corpay
CPAY
$21.9B
| $112M | 0.4% |
+469,794
| New | +$112M |
|
60
PVH
PVH
$4.04B
| $105M | 0.38% |
1,762,098
+239,114
| +16% | +$14.3M |
|
|
CTLT
61
DELISTED
CATALENT, INC.
CTLT
| $102M | 0.37% |
1,185,679
-308,024
| -21% | -$26.4M |
|
|
INBX
62
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $95.5M | 0.35% |
+5,305,866
| New | +$95.5M |
|
63
PMV Pharmaceuticals
PMVP
$66.2M
| $93.8M | 0.34% |
+2,641,840
| New | +$93.8M |
|
|
HZNP
64
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $91.2M | 0.33% |
1,173,744
-297,675
| -20% | -$23.1M |
|
65
Royalty Pharma
RPRX
$15.4B
| $82M | 0.3% |
1,948,064
-566,921
| -23% | -$23.9M |
|
66
Labcorp
LH
$22.9B
| $80.9M | 0.29% |
+500,264
| New | +$80.9M |
|
67
Allstate
ALL
$52B
| $77.4M | 0.28% |
822,509
-947,061
| -54% | -$89.2M |
|
68
Visa
V
$672B
| $64.3M | 0.23% |
321,595
+156,706
| +95% | +$31.3M |
|
69
GoHealth
GOCO
$76.7M
| $61M | 0.22% |
+312,468
| New | +$61M |
|
70
Liberty Media Series C
FWONK
$25.5B
| $51.8M | 0.19% |
1,475,930
-513,526
| -26% | -$18M |
|
|
KRTX
71
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $51.3M | 0.19% |
+663,890
| New | +$51.3M |
|
72
Insulet
PODD
$22.7B
| $50.7M | 0.18% |
+214,332
| New | +$50.7M |
|
73
Vertex
VERX
$4.01B
| $46.7M | 0.17% |
+2,031,639
| New | +$46.7M |
|
74
Pacific Biosciences
PACB
$369M
| $44.6M | 0.16% |
+4,518,623
| New | +$44.6M |
|
|
BMY.RT
75
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $41.4M | 0.15% |
18,401,269
-566,750
| -3% | -$1.28M |
|